Am J Clin Pathol

1. ZHAO X, Balmaceda A, Abiera VS, Rimsza LM, et al
   An immunohistochemical germinal center B-cell dark zone signature identifies Burkitt lymphoma and molecular high-grade B-cell lymphomas.
   Am J Clin Pathol. 2025 Aug 3:aqaf074. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Hematol

2. THIRUVENGADAM SK, Ahn KW, Patel J, Lian Q, et al
   CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.
   Am J Hematol. 2025 Aug 5. doi: 10.1002/ajh.70027.
   

   >> Share

   
   
3. HRISTOV AC, Tejasvi T, Wilcox RA
   Mycosis Fungoides, Sezary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.
   Am J Hematol. 2025;100:1603-1628.
   

   >> Share

   
   

   
   Cancer Lett

4. LI Y, McIntosh J, Jiang V, Yan F, et al
   BCL-2/BCL-X(L) dual inhibition triggers Gasdermin D-mediated pyroptosis in mantle cell lymphoma.
   Cancer Lett. 2025;632:217961.
   

   >> Share

   
   

   
   Dtsch Med Wochenschr

5. FREI-STUBER L, Utpatel K, Hammer S, Nowak D, et al
   [Recurrent non-Hodgkin lymphoma of various subtypes and localizations of manifestation - case report of a recognized occupational disease caused by ionizing radiation].
   Dtsch Med Wochenschr. 2025;150:969-974.
   

   >> Share

   
   

   
   Int J Cancer

6. LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV
   Correlations between new HIV infections and hospital admissions for non-Hodgkin lymphoma in Brazil.
   Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076.
   

   >> Share

   
   

   
   Leuk Lymphoma

7. ZHOU X, Ling Y, Ma J, Lin Z, et al
   Clinical characteristics and prognosis of primary central nervous system lymphoma in China: a single-center retrospective analysis of 325 patients.
   Leuk Lymphoma. 2025 Aug 8:1-12. doi: 10.1080/10428194.2025.2541016.
   

   >> Share

   
   
8. SHARIFF N, Chun FJ, Parsons SK, Hodgson DC, et al
   The evolution of treatment for pediatric advanced stage classic Hodgkin lymphoma - a narrative literature review.
   Leuk Lymphoma. 2025 Aug 8:1-13. doi: 10.1080/10428194.2025.2531154.
   

   >> Share

   
   
9. SUPERDOCK MA, Rimsza LM, Wallace DS, Strawderman M, et al
   Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.
   Leuk Lymphoma. 2025 Aug 6:1-4. doi: 10.1080/10428194.2025.2539231.
   

   >> Share

   
   
10. XIAO A, Chen L, Pak S, Lee B, et al
    Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma.
    Leuk Lymphoma. 2025 Aug 5:1-9. doi: 10.1080/10428194.2025.2540442.
    

    >> Share

    
    

    
    Leukemia

11. SUZUKI K, Kusayanagi S, Kuze Y, Hata M, et al
    Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-beta axis in adult T-cell leukemia/lymphoma.
    Leukemia. 2025 Aug 4. doi: 10.1038/s41375-025-02725.
    

    >> Share

    
    

    
    N Engl J Med

12. SVOBODA J, Hexner E, June CH
    Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply.
    N Engl J Med. 2025;393:620.
    

    >> Share

    
    
13. VAIRAMOORTHY N, Kazi B, Patil V
    Enhanced CAR T-Cell Therapy for Relapsed Lymphoma.
    N Engl J Med. 2025;393:619-620.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share